Skip to main content

Table 2 Currently available diagnostic/classification criteria for SD

From: Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel

 

sJIA

AOSD

ILAR 2004 [19]

PRINTO 2018 [20]

Yamaguchi 1992 [21]

Fautrel 2002 [18]

Major criteria

• Arthritis in ≥ 1 joint with or preceded by fever ≥ 2 weeks (documented to be daily for ≥ 3 days), with ≥ 1 day of:

 ◦ Evanescent (non-fixed) erythematous rash

 ◦ General lymph node enlargement

 ◦ Hepatomegaly and/or splenomegaly

 ◦ Serositis

• Onset before age 18 years

• Fever for ≥ 3 consecutive days, reoccurring over 2 weeks

• Evanescent (non-fixed) erythematous rash

• Arthritis

• Fever ≥ 39 °C lasting ≥ 1 week

• Arthralgia or arthritis lasting ≥ 2 weeks

• Typical rash

• Leukocytosis ≥ 10,000/µL with ≥ 80% neutrophils

• Spiking fever ≥ 39 °C

• Arthralgia

• Transient erythema

• ≥ 80% granulocytes

• Pharyngitis

• Glycosylated ferritin < 20%

Minor criteria

• Generalized lymph node enlargement and/or hepatomegaly and/or splenomegaly

• Serositis

• Arthralgia lasting ≥ 2 weeks (in the absence of arthritis

• Leukocytosis (≥ 15,000/mm3) with neutrophilia

• Sore throat

• Lymphadenopathy

• Hepatomegaly or splenomegaly

• Abnormal liver function tests

• Negative RF and ANA

• Maculopapular rash

• Leucocytes ≥ 10,000/µL

Exclusion criteria

• All other forms of JIA must be excluded

• Other known conditions

• Infections, malignancies, and all other conditions that may mimic AOSD

Additional criteria

• Fever (as described) accompanied by either the 2 other major criteria, or 1 of the major criterion and 2 minor criteria

• The presence of 5 criteria listed above, including ≥ 2 major criteria

• The presence of 4 major criteria listed above, or 3 major and 2 minor criteria

  1. ANA antinuclear antibodies, AOSD adult-onset Still’s disease, ILAR International League of Associations for Rheumatology, JIA juvenile idiopathic arthritis, PRINTO Paediatric Rheumatology International Trials Organisation, RF rheumatoid factor, SD Still’s disease, sJIA systemic juvenile idiopathic arthritis